ClinicalTrials.gg
Drug

Methylnaltrexone clinical trials

Also written Relistor, MOA-728 and MNTX.

studies test it
59
open now
2
in phase 3
12
first study started
2002

How each study uses methylnaltrexone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the methylnaltrexone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Apr 2008 · RELISTOR · NDA 021964 (FDA, Drugs@FDA)
European Union
1 Jul 2008 · Relistor · EMEA/H/C/000870 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Methylnaltrexone
19
Methylnaltrexone bromide
8
IV Methylnaltrexone (MNTX)
5
N-methylnaltrexone bromide (MOA-728)
3
Methylnaltrexone (MNTX)
3

Brand

Relistor
18

Development codes

MOA-728
16

Other names

MNTX
3

Studies by the year they started

59 studies that test it; most in 2007 (10)

Studies that test methylnaltrexone, by start year
YearStudies
20023
20033
20042
20051
20069
200710
20084
20097
20106
20111
20132
20141
20152
20161
20171
20191
20203
20211
20241

By phase

A phase 1/2 study counts in both.

Phase 1
23
Phase 2
11
Phase 3
12
Phase 4
12
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 40 · Other 19

Bausch Health Americas, Inc. (39) · University Medicine Greifswald (2) · Region Örebro County (2) · University of Missouri-Columbia (1) · Ohio State University (1) · Karolinska University Hospital (1) · University of Florida (1) · Universitaire Ziekenhuizen KU Leuven (1)

Often tested with

Tested in the same studies.

Naloxone (3) · Naloxegol (1) · Codeine (1) · Erythromycin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test methylnaltrexone.

Studies

Open first, then newest update. How each study uses methylnaltrexone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 59

See all 59 studies that test methylnaltrexone →

Given beside what is tested · 1 — methylnaltrexone is usual care or a partner of the new treatment

Codes

What other systems call methylnaltrexone · ClinicalTrials.gg INT002974

  • MeSH (NLM) C032257methylnaltrexoneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 0RK7M7IABEMETHYLNALTREXONEConfirmed FDA, NLM
  • RxNorm 29899One source FDA
  • NCI Thesaurus C48403MethylnaltrexoneOne source FDA

Also registered as methylnaltrexone bromide (UNII RFO6IL3D3M · RxNorm 979111).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.